Ron Squarer

Ron Squarer has an estimated net worth of $28.2 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., Deciphera Pharmaceuticals, Inc., ARRAY BIOPHARMA INC, HOSPIRA INC, ADC Therapeutics SA, and Nuvalent, Inc..

2017 was Ron Squarer's most active year for acquiring shares with 12 total transactions. Ron Squarer's most active month to acquire stocks was the month of November. 2019 was Ron Squarer's most active year for disposing of shares, totalling 18 transactions. Ron Squarer's most active month to dispose stocks was the month of June. 2017 saw Ron Squarer paying a total of $4,985,625.44 for 1,664,960 shares, this is the most they've acquired in one year. In 2019 Ron Squarer cashed out on 4,562,346 shares for a total of $19,190,816.64, their largest year based on trade value.